Melbourne, April 27, 2015 - (ABN Newswire) - Rhinomed (ASX:RNO) presented the keynote address titled ‘Changing the Way the World Breathes’ at the 2015 Master Investor Show, held in London on 25th April 2015.
The Master Investor Show is regarded as the number 1 investment event in the UK and secured over 4,700 attendees - making it the largest show in the event’s 13 year history.
Sir Steve Redgrave, CBE, heralded as one of the greatest Olympians of all time, having won 5 consecutive Olympic gold medals, presented alongside Rhinomed CEO Michael Johnson at the Show and met with investors through the day.
Sir Steve, who is a long-standing shareholder of Rhinomed and a brand ambassador, used the opportunity to highlight the importance of sleep in recovery and sport performance. “Medical research is increasingly highlighting the impact sleep has on physical and mental wellbeing. The way we breathe at night plays a critical role in delivering good sleep,” said Michael Johnson, CEO Rhinomed.
“Snoring in particular, continues to be linked to major health issues - with recent research now linking snoring with dementia1.”
Rhinomed’s patented nasal breathing technologies are designed to radically alter the way people breathe, sleep, maintain their health, and even take medication.
“In addressing the way we breathe at night - we are able to address a number of significant health issues that otherwise create major and chronic long-term health issues for patients and add significant cost to the health system,” said Johnson
Rhinomed’s presentation builds upon a survey undertaken by YouGov in the UK, where in a study of over 2,000 adults, 34% of people with snoring partners insisted on separate rooms for their partner when sleep loss becomes too much for them.
The impact of sleep loss was of particular concern, with a third of people worrying about the impact sleep loss had on their physical health (36%), mental health (34%) and relationship with their partner (31%).
According to the survey, many are disappointed with currently available treatments. “The survey data confirms that snoring can have a hugely negative impact on people’s health and intimate relationships. The good news is that by adopting technology we developed for athletes to improve their performance, we can now help snorers improve the quality of their sleep and lives,” Johnson said.
The Master Investor Show follows a successful week of meetings in the UK for Rhinomed, which also coincided with UK National Stop Snoring Week. As part of the activities, Sir Steve Redgrave discussed Rhinomed’s breathing technologies and the effect of sleep quality on the Sky News UK Sunrise program on Monday 20th April.
WEB: Rhinomed Addresses 2015 Master Investor Show
About: Rhinomed Ltd
Rhinomed Limited is a medical technology firm that focuses on nasal, respiratory and breathing management technologies. The company is monetising its technology portfolio in the Sport and recreation market, Sleep, Wellbeing and Drug delivery markets.
Rhinomed’s technology is designed to radically improve the way you breathe sleep, maintain your health and take medication.
The first product brought to market is the Turbine(TM). A radical nasal technology that improves airflow by an average of 38%, the Turbine(TM) is an internal nasal dilator that has since it’s launch in January 2014 in Australia, grown to be widely adopted by leading cyclists and triathletes globally.
Now shipped to over 36 countries and with a growing global distribution base, the Turbine(TM) is providing all those undertaking aerobic activities with an opportunity to breathe better, perform better and get more enjoyment from their sport and exercise.
Contact:
Media Enquiries
Michael Johnson
CEO & Managing Director
T: +61 (03) 8416 0900
mjohnson@rhinomed.global
Help employers find you! Check out all the jobs and post your resume.
